347 related articles for article (PubMed ID: 35453625)
41. Resveratrol prevents combined prenatal N
Chen HE; Lin YJ; Lin IC; Yu HR; Sheen JM; Tsai CC; Huang LT; Tain YL
J Nutr Biochem; 2019 Aug; 70():28-37. PubMed ID: 31108332
[TBL] [Abstract][Full Text] [Related]
42. Developmental Origins of Chronic Kidney Disease: Should We Focus on Early Life?
Tain YL; Hsu CN
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208659
[TBL] [Abstract][Full Text] [Related]
43. Maternal Gut Dysbiosis Alters Offspring Microbiota and Social Interactions.
Zhang Z; Xue C; Ju M; Guo J; Wang M; Yi S; Yi X
Microorganisms; 2021 Aug; 9(8):. PubMed ID: 34442821
[TBL] [Abstract][Full Text] [Related]
44. Microbiota and Hypertension: Role of the Sympathetic Nervous System and the Immune System.
Robles-Vera I; Toral M; Duarte J
Am J Hypertens; 2020 Oct; 33(10):890-901. PubMed ID: 32614942
[TBL] [Abstract][Full Text] [Related]
45. Exposure to Amoxicillin in Early Life Is Associated With Changes in Gut Microbiota and Reduction in Blood Pressure: Findings From a Study on Rat Dams and Offspring.
Galla S; Chakraborty S; Cheng X; Yeo JY; Mell B; Chiu N; Wenceslau CF; Vijay-Kumar M; Joe B
J Am Heart Assoc; 2020 Jan; 9(2):e014373. PubMed ID: 31928175
[TBL] [Abstract][Full Text] [Related]
46. Microbiome and hypertension: where are we now?
Vallianou NG; Geladari E; Kounatidis D
J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):83-88. PubMed ID: 31809283
[TBL] [Abstract][Full Text] [Related]
47. The Association between Early-Life Gut Microbiota and Long-Term Health and Diseases.
Sarkar A; Yoo JY; Valeria Ozorio Dutra S; Morgan KH; Groer M
J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33504109
[TBL] [Abstract][Full Text] [Related]
48. Amino Acids and Developmental Origins of Hypertension.
Hsu CN; Tain YL
Nutrients; 2020 Jun; 12(6):. PubMed ID: 32545526
[TBL] [Abstract][Full Text] [Related]
49. The impact of maternal exposure to antibiotics on the development of child gut microbiome.
Miyoshi J; Hisamatsu T
Immunol Med; 2022 Jun; 45(2):63-68. PubMed ID: 34392799
[TBL] [Abstract][Full Text] [Related]
50. Metabolic Syndrome Programming and Reprogramming: Mechanistic Aspects of Oxidative Stress.
Tain YL; Hsu CN
Antioxidants (Basel); 2022 Oct; 11(11):. PubMed ID: 36358480
[TBL] [Abstract][Full Text] [Related]
51. Perinatal Resveratrol Therapy to Dioxin-Exposed Dams Prevents the Programming of Hypertension in Adult Rat Offspring.
Hsu CN; Hung CH; Hou CY; Chang CI; Tain YL
Antioxidants (Basel); 2021 Aug; 10(9):. PubMed ID: 34573025
[TBL] [Abstract][Full Text] [Related]
52. The developing gut microbiota and its consequences for health.
Butel MJ; Waligora-Dupriet AJ; Wydau-Dematteis S
J Dev Orig Health Dis; 2018 Dec; 9(6):590-597. PubMed ID: 29562949
[TBL] [Abstract][Full Text] [Related]
53. Microbial Peer Pressure: The Role of the Gut Microbiota in Hypertension and Its Complications.
Muralitharan RR; Jama HA; Xie L; Peh A; Snelson M; Marques FZ
Hypertension; 2020 Dec; 76(6):1674-1687. PubMed ID: 33012206
[TBL] [Abstract][Full Text] [Related]
54. The role of the microbiome for human health: from basic science to clinical applications.
Mohajeri MH; Brummer RJM; Rastall RA; Weersma RK; Harmsen HJM; Faas M; Eggersdorfer M
Eur J Nutr; 2018 May; 57(Suppl 1):1-14. PubMed ID: 29748817
[TBL] [Abstract][Full Text] [Related]
55. Do Antibiotics Cause Obesity Through Long-term Alterations in the Gut Microbiome? A Review of Current Evidence.
Vallianou N; Dalamaga M; Stratigou T; Karampela I; Tsigalou C
Curr Obes Rep; 2021 Sep; 10(3):244-262. PubMed ID: 33945146
[TBL] [Abstract][Full Text] [Related]
56. Gut dysbiosis is linked to hypertension.
Yang T; Santisteban MM; Rodriguez V; Li E; Ahmari N; Carvajal JM; Zadeh M; Gong M; Qi Y; Zubcevic J; Sahay B; Pepine CJ; Raizada MK; Mohamadzadeh M
Hypertension; 2015 Jun; 65(6):1331-40. PubMed ID: 25870193
[TBL] [Abstract][Full Text] [Related]
57. Lessons to Learn from the Gut Microbiota: A Focus on Amyotrophic Lateral Sclerosis.
Calvo AC; Valledor-Martín I; Moreno-Martínez L; Toivonen JM; Osta R
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627250
[TBL] [Abstract][Full Text] [Related]
58. Role of the microbiota in hypertension and antihypertensive drug metabolism.
Mishima E; Abe T
Hypertens Res; 2022 Feb; 45(2):246-253. PubMed ID: 34887530
[TBL] [Abstract][Full Text] [Related]
59. Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease.
Koopman N; Molinaro A; Nieuwdorp M; Holleboom AG
Aliment Pharmacol Ther; 2019 Sep; 50(6):628-639. PubMed ID: 31373710
[TBL] [Abstract][Full Text] [Related]
60. Impact of Prebiotics on Enteric Diseases and Oxidative Stress.
Gao J; Azad MAK; Han H; Wan D; Li T
Curr Pharm Des; 2020; 26(22):2630-2641. PubMed ID: 32066357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
